Pharmacokinetic study of partially pure gamma-interferon in cancer patients.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Cancer Research

• Publication date

  1984-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 6430557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon therapy: Pharmacokinetic and pharmacological aspects

  2005cited by this paper
• Alpha interferon for induction of remission in hairy-cell leukemia.

  1984cited by this paper
• Molecular weight of the functional unit of human leukocyte, fibroblast, and immune interferons.

  1983cited by this paper
• A unique set of polypeptides is induced by gamma interferon in addition to those induced in common with alpha and beta interferons.

  1983cited by this paper
• Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia.

  1983cited by this paper
• The anticellular and protein-inducing activities of human gamma interferon preparations are mediated by the interferon.

  1983cited by this paper
• A simple and efficient method for the purification of human gamma interferon.

  1983cited by this paper
• Renal cell carcinoma: antitumor effects of leukocyte interferon.

  1983cited by this paper
• A simple and efficient method for the production of human gamma interferon.

  1983cited by this paper
• Immunoregulation by gamma-interferon?

  1982cited by this paper
• Comparisons of dose-response data for various standard and recombinant DNA-derived human interferons.

  1982cited by this paper
• Gamma interferon (IFN gamma) and IFN alpha/beta suppress murine myeloid colony formation (CFU-C)N: magnitude of suppression is dependent upon level of colony-stimulating factor (CSF).

  1982cited by this paper
• The role of liver in the catabolism of human alpha- and beta-interferon.

  1982cited by this paper
• Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells

  1982cited by this paper
• Structure of the human immune interferon gene

  1982cited by this paper
• Expression of human immune interferon cDNA in E. coli and monkey cells

  1982cited by this paper
• Sequence and structural homologies among type I and type II interferons

  1982cited by this paper
• Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

  1982cited by this paper
• Pharmacokinetic comparison of leukocyte and Escherichia coli-derived human interferon type alpha.

  1982cited by this paper
• Stimulation of human gamma interferon production by diterpene esters

  1981cited by this paper
• Evidence that types I and II interferons have different receptors

  1981cited by this paper
• Differences between human α (leukocyte) and β (fibroblast) interferons

  1981cited by this paper
• Convenient assay for interferons

  1981cited by this paper
• Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon.

  1980cited by this paper
• Human immune interferon: induction in lymphoid cells by a calcium ionophore

  1980cited by this paper
• Towards tumor therapy with interferons, part II. Interferons: in vivo effects.

  1980cited by this paper
• Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.

  1980cited by this paper
• Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.

  1980cited by this paper
• The Interferon System

  1979cited by this paper
• Immune Interferon Activates Cells More Slowly Than Does Virus-Induced Interferon 1

  1978cited by this paper
• Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.

  1978cited by this paper
• Circulating interferon in man after administration of exogenous human leukocyte interferon.

  1975cited by this paper

• IFNγ in human sepsis: a scoping review

  2025cites this paper
• Generation and Functional In Vitro Analysis of Semliki Forest Virus Vectors Encoding TNF-α and IFN-γ

  2017cites this paper
• Pharmacokinetic and Pharmacodynamic Relationship of AMG 811, An Anti-IFN-γ IgG1 Monoclonal Antibody, in Patients with Systemic Lupus Erythematosus

  2014cites this paper
• Manipulating the immune response of Tasmanian Devils to target Devil Facial Tumour Disease

  2013cites this paper
• Contributions of Pharmacologic Studies of Anticancer Drugs to Their Clinical Trials

  2010cites this paper
• Abstract and Introduction

  2010cites this paper
• Developmental therapeutics and the design of clinical trials

  2009cites this paper
• Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis.

  2008cites this paper
• Matrices and scaffolds for protein delivery in tissue engineering.

  2007cites this paper
• Catabolic Sites of Human Interferon-¥

  2007cites this paper
• Pharmacokinetics, Single-Dose Tolerance, and Biological Activity of Recombinant 7-lnterferon in Cancer Patients1

  2006cites this paper
• Gemini cationic surfactant-based delivery systems for non-invasive cutaneous gene therapy

  2006cites this paper
• Liposomal cytokines in the treatment of infectious diseases and cancer.

  2005cites this paper
• lnterferon-7 Inhibits Collagen Synthesis by Human Tenon ' s Capsule Fibroblasts In Vitro

  2005cites this paper
• Liposomal cytokines in the treatment of infectious diseases and cancer.

  2005cites this paper
• Establishment and Characterization of a Human Gastric Carcinoma Cell Line TMC-1

  2004influential citation
• Application of a new preclinical drug screening system for cancer of the large bowel

  2004cites this paper
• Interferons: Current status and future directions of this prototypic biological

  2004cites this paper
• Subcutaneous recombinant gamma interferon in cancer patients: toxicity, pharmacokinetics, and immunomodulatory effects

  2004cites this paper
• Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay

  2004cites this paper
• A phase I trial of recombinant gamma interferon in patients with cancer

  2004cites this paper
• Interferon‐γ therapy: Evaluation of routes of administration and delivery systems

  2002cites this paper
• Interferon-gamma therapy: evaluation of routes of administration and delivery systems.

  2002cites this paper
• Th1/Th2 differentiation and cross-regulation

  1999cites this paper
• Heparin Decreases the Blood Clearance of Interferon-γ and Increases Its Activity by Limiting the Processing of Its Carboxyl-terminal Sequence*

  1996cites this paper
• Combination therapy with interferon-γ and interleukin-2 for the treatment of metastatic melanoma

  1996cites this paper
• Effect of liposome-encapsulation on immunomodulating and antiviral activities of interferon-γ☆

  1996cites this paper
• Combination therapy with interferon-gamma and interleukin-2 for the treatment of metastatic melanoma.

  1996cites this paper
• Growth-Factor Delivery in Tissue Engineering

  1996cites this paper
• A phase I trial of recombinant gamma interferon administered intravenously on a daily × 5 schedule

  1996cites this paper
• Single institution experience with recombinant gamma-interferon in the treatment of patients with metastatic renal cell carcinoma.

  1996cites this paper
• Promising polymers.

  1995cites this paper
• Preparation and characterization of interferon-γ-containing liposomes

  1995cites this paper
• Pharmacology and side-effects of interferons.

  1994cites this paper
• Pharmacokinetics and cancer: successes, failures and future prospects.

  1993cites this paper
• Synergic in vitro effects of interleukin‐2 and τ‐interferon on the migration of blood monocytes from control subjects and patients with lung cancer

  1993cites this paper
• Interferon-gamma: a key immunoregulatory lymphokine.

  1993cites this paper
• Pharmacokinetics and Metabolism of Therapeutic Cytokines

  1992cites this paper
• Dose-independent pharmacokinetics of recombinant human interferon-αA in rabbits

  1992cites this paper
• Immunologie der Tumoren des Urogenitaltrakts

  1992cites this paper
• Interferon-gamma induced by administration of recombinant interleukin-2 to patients with cancer: kinetics, dose dependence, and correlation with physiological and therapeutic response.

  1992cites this paper
• Vinblastine fails to improve response of renal cancer to interferon alfa-n1: high response rate in patients with pulmonary metastases.

  1991cites this paper
• Specific uptake of asialofetuin-tacked liposomes encapsulating interferon-gamma by human hepatoma cells and its inhibitory effect on hepatitis B virus replication.

  1991cites this paper
• Interferon-gamma inhibits collagen synthesis by human Tenon's capsule fibroblasts in vitro.

  1991cites this paper
• Clinical Pharmacokinetics of Interferons

  1990cites this paper
• Interferon gamma encapsulated into liposomes enhances the activity of monocytes and natural killer cells and has antiproliferative effects on tumor cells in vitro

  1990cites this paper
• In vivo biological response to recombinant interferon-gamma during a phase I dose-response trial in patients with metastatic melanoma.

  1990cites this paper
• The role of interferons in the control of HIV replication in macrophages.

  1990cites this paper
• Pharmacokinetic Study of Liposome-Encapsulated Human Interferon-γ after Intravenous and Intramuscular Injection in Mice

  1990cites this paper
• Antiviral and Antiproliferative Properties of Liposome-Associated Human Interferon-α

  1990cites this paper
• Recombinant Gamma‐Interferon Has Activity in Chronic Myeloid Leukemia

  1990cites this paper
• Interferon-gamma: a review.

  1989cites this paper
• Catabolism of therapeutic proteins and peptides with implications for drug delivery

  1989cites this paper
• A phase I trial of recombinant human interferon-γ in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS)

  1989cites this paper
• Recombinant interferon‐γ lacks activity against metastatic colorectal cancer but increases serum levels of ca 19‐9

  1989cites this paper
• Clinical Aspects of Interferon Therapy in Human Cancer

  1988cites this paper
• Phase I study of recombinant gamma-interferon (rIFN-gamma).

  1988cites this paper
• Clearance and distribution of recombinant murine gamma-interferon in mice.

  1988cites this paper
• Decreased locomotor activity produced by repeated, but not single, administration of murine-recombinant interferon-gamma in mice.

  1988cites this paper
• Effects of interferons in neoplastic diseases of man.

  1988cites this paper
• Pharmacokinetics of recombinant human interferon-gamma in the rhesus monkey after intravenous, intramuscular, and subcutaneous administration.

  1988cites this paper
• Divergent dose-related effects of gamma-interferon therapy on in vitro antibody-dependent cellular and nonspecific cytotoxicity by human peripheral blood monocytes.

  1988cites this paper
• Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.

  1988cites this paper
• Plasma and tissue pharmacokinetics of human interferon-alpha in the rat after its intravenous administration.

  1988cites this paper
• In vitro suppression of anti-DNA antibody and immunoglobulin synthesis in systemic lupus erythematosus patients by human gamma interferon.

  1988cites this paper
• A prospective randomized trial of alpha 2B-interferon/gamma-interferon or the combination in advanced metastatic renal cell carcinoma.

  1988cites this paper
• The immunologic treatment of cancer

  1988cites this paper
• Pharmacokinetics of Interferons and Practical Implications

  1988cites this paper
• Pharmacokinetics of Recombinant Murine Interferon-γ in Mice

  1988cites this paper
• Pharmacokinetics of Recombinant Murine Interferon-γ and Human Interferon-αA/D(Bgl) Administered in Concert and Their Influence on Natural Killer Cell Function in Mice

  1988cites this paper
• Alpha‐ and gamma‐interferon (IFNα, IFNγ) but not interleukin‐1 (IL‐1) modulate synthesis and secretion of β2‐microglobulin by hepatocytes

  1988cites this paper
• Alpha- and gamma-interferon (IFNa, IFNy) but not interleukin-I (IL-I ) modulate synthesis and secret ion of p2-microg lo bu I in by hepatocytes

  1988cites this paper
• Current status of interferon therapy in oncology.

  1987cites this paper
• Metabolism of protein anticancer agents.

  1987cites this paper
• [Studies on the antitumor effects of human interferon (2). Effects of massive pulsatile administration of rIFN-gamma on advanced renal cell carcinoma].

  1987cites this paper
• Hematologic response of four patients with smoldering acute myelogenous leukemia to partially pure gamma interferon.

  1987cites this paper
• Toxicity of interferon and interleukin

  1987cites this paper
• Interleukin 2 inhibits in vitro granulocyte-macrophage colony formation.

  1987cites this paper
• Interferons in the Treatment of Human Neoplasms

  1987cites this paper
• A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma.

  1987cites this paper
• Alkylating Drugs and Other Agents

  1987cites this paper
• Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinoma.

  1987cites this paper
• Lymphocyte phenotype and lymphokines following anti‐thymocyte globulin therapy in patients with aplastic anaemia

  1987cites this paper
• Gamma-interferon: physiology and speculation on its role in medicine.

  1987cites this paper
• Pharmacokinetics and tissue disposition of the biological response modifier BAY i 7433 (copovithane) in patients with cancer

  1986cites this paper
• Chronic myelogenous leukaemia: haematological remissions with alpha interferon

  1986cites this paper
• Phase I trial of recombinant interferon gamma in cancer patients.

  1986cites this paper
• Lymphokines and hematopoiesis.

  1986cites this paper
• Effect of hyperthermia on combination interferon treatment: enhancement of the antiproliferative activity against murine B-16 melanoma.

  1986cites this paper
• Phase I/II trial of human recombinant interferon gamma in renal cell carcinoma.

  1986cites this paper
• Phase I trial of recombinant interferon gamma by 1-hour i.v. infusion.

  1986cites this paper
• In vivo induction of H‐2K/D antigens by recombinant interferon‐γ

  1986cites this paper
• Effect of hyperthermia on the antiproliferative activities of murine alpha-, beta-, and gamma-interferon: differential enhancement of murine gamma-interferon.

  1986cites this paper
• Biologic effects of gamma interferon pre-treatment followed by monoclonal antibody 17-1A administration in patients with gastrointestinal carcinoma.

  1986cites this paper
• Phase I study of multiple dose intramuscularly administered recombinant gamma interferon.

  1986cites this paper
• Direct and indirect effects of human recombinant gamma-interferon on tumor cells in a clonogenic assay.

  1986cites this paper
• Phase I clinical trial of an MAF-containing lymphoblastoid cell line supernatant.

  1986cites this paper
• Pharmacokinetic Studies with Human and Rat Interferons-γ in Different Species

  1986cites this paper
• Interferon treatment of human neoplasia.

  1986cites this paper
• Effect of Hyperthermia on the Antiproliferative Activities of Murine α-, β-, and γ-Interferon: Differential Enhancement of Murine γ-Interferon

  1986cites this paper